Clinical Trials in Baltimore

Showing 23241-23260 of 23,476 trials

T Cell Immunotherapy for Multiple Myeloma Patients Undergoing a Bone Marrow Transplant

NCT00048464

Patients will have immune cells collected and then expanded outside of the body. Patients will undergo standard treatment with high dose chemotherapy followed by peripheral blood stem cell transplantation. Three days following the transplant, patients will receive an infusion of a large number of expanded immune cells. The goal of the study will be to determine the safety as well as potential efficacy of this treatment.

Multiple Myeloma

Xcyte Therapies35 participantsStarted Oct 2002

Los Angeles, California, United States • San Diego, California, United States • San Francisco, California, United States +3 more locations

COMPLETEDPhase 2< 1 mile

Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 To Treat Small-Volume Ovarian, Peritoneal, Fallopian Tube Cancer

NCT00074867

The purpose of this study is to determine whether CP-547,632, an oral VEGFR-2 tyrosine kinase inhibitor is effective in the treatment of epithelial ovarian cancer, primary peritoneal serous cancer, or fallopian tube cancer for patients who have failed first line platinum-based therapy and have a persistent rising CA-125.

Ovarian NeoplasmsPeritoneal NeoplasmsFallopian Tube Neoplasms

Pfizer29 participantsStarted Oct 2003

Los Angeles, California, United States • Santa Monica, California, United States • Baltimore, Maryland, United States +6 more locations

T Cell Immunotherapy for Multiple Myeloma Patients Undergoing a Bone Marrow Transplant

Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 To Treat Small-Volume Ovarian, Peritoneal, Fallopian Tube Cancer

Find Trials by Condition in Baltimore

ARISE - Aggressive Reduction of Inflammation Stops Events

CoolCap Trial, Treatment of Perinatal Hypoxic-Ischemic Encephalopathy

Efficacy of Opioids and Mexiletine for the Treatment of Postamputation Pain

The Labor and Delivery Teamwork Intervention Trial

A Dose Study of Doxil in a Dose Dense, 14 Day CDOP/Rituximab Regimen for Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma (NHL)> 60 Years or With Compromised Cardiac Status.

Peri-Procedural Myocardial Infarction, Platelet Reactivity, Thrombin Generation, and Clot Strength: Differential Effects of Eptifibatide + Bivalirudin Versus Bivalirudin

Effects of Lutein in Retinitis Pigmentosa

The Effect of Good Bacteria on Nonalcoholic Fatty Liver Disease in Diabetics

Use of Acupuncture for Dental Pain: Testing a Model

An Efficacy Evaluation of 2 Different Bowel Cleansing Preparations in Adult Subjects

Study to Evaluate the Efficacy, Safety, and Tolerability of E7070 in Metastatic Breast Cancer Patients

Clinical Investigation of the SelectSecure Pacing Lead

Study of Abarelix in Androgen-Independent Prostate Cancer Progressing After Agonist Therapy

A Phase 2, Randomized, Open-Label Study Of Single Agent CI-1033 In Patients With Advanced Non-Small Cell Lung Cancer

Study for Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)

Chemotherapy for Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma

A Study of the Safety and Efficacy of Multiple Doses of ABT-089 in Subjects With Alzheimer's Disease

Glaser Obesity Study